OB
Oterus Biosystems develops platform technology to enhance In Vitro Fertilization (IVF) efficiency by introducing a new functional test for embryo viability. This approach is coupled with an innovative method for embryo implantation designed to increase IVF success rates. The technology aims to reduce the emotional and financial strain associated with multiple IVF cycles without adding patient treatment burden or safety risks.
Updated 4 months ago
Funding
Funding not disclosed
Funding rounds are not available yet.
Founders
Product
Features
- Oterus Biosystems develops platform technology to enhance In Vitro Fertilization (IVF) efficiency by introducing a new functional test for embryo viability. This approach is coupled with an innovative method for embryo implantation designed to increase IVF success rates. The technology aims to reduce the emotional and financial strain associated with multiple IVF cycles without adding patient treatment burden or safety risks.